RAP media thread., page-1621

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 1621 Last

Share
Profile

Follow
Dhm

2,412 Posts.

3557

07/12/20

17:20

Post #: 49399833
Share

Originally posted by Dhm: ↑

I like some of these comments by TK:

"We have a very experienced board of directors, and I'd just like to point out the recent addition in the last six months of Dr. Michael Stein. Mike is an experienced doctor entrepreneur, and importantly was the founding CEO of Doctor Care Anywhere, one of the UK's leading telehealth providers. So he provides great insights and access into the UK and European telehealth space.""We have a joint development agreement that we hope to enter into with RBs. That's the next stage of the RB, the direct-to-consumer product. We expect that before the end of this year. We're expecting to file our FDA follow-up. So ResAppDX through to the US the end of this quarter or early next year. And then we have the Medgate pilot startup, and the Ilara pilot outcomes early next year. With SleepCheck we're still on track for launching Android before the end of this year, before Christmas. And we're also working towards a SleepCheck FDA submission early next year."

Much to look forward to. I hope. It could be a disaster if we can't bring home the bacon.

Expand

We really were kidding ourselves when we dissed the USA as a primary market when the FDA asked for more justification. We all pretended we didn't need the US and refocused our interest on UK and Europe. But if (when!) the FDA gives us approval as a Class 2a diagnostic tool all will be forgiven. However, considering the US market is so important, why has it taken over 9 months to get to APPLY again. Well I suppose I know the answer, COVID, an inefficient partner in Experion, and complicated questions from the FDA. Lets hope we are ready to deliver winning answers for a fast turnaround.

RAP Price at posting: 9.0¢ Sentiment: Hold Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Making money: How many microcaps should be in an investor's portfolio?

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What each US election outcome would mean for Australian companies & investors

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?